Clinical Trial

Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.

Name: Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis. — clinical trial record (NCT07763821)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will identify the level of serum Riboneuclease 1 in systemic lupus patients and compare between its level in lupus nephritis and non nephritis.

Trial Details

NCT Number	NCT07763821
Lead Sponsor	Assiut University
Conditions	System Lupus Erythematosus(SLE)
Enrollment	128 participants
Start Date	2026-09-30
Primary Completion	2027-09-30 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-13